Hemangeol
Payments companies reported to CMS as associated with Hemangeol. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Hemangeol, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Hemangeol
These are the largest totals companies reported as associated with Hemangeol. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Browning | San Antonio, TX | Dermatology | $11,477.81 |
| Xavier Sanchez Flores | Dorado, PR | Pediatric Dermatology | $7,585.81 |
| Daniela Russi | Phoenix, AZ | Pediatric Dermatology | $6,263.19 |
| Elizabeth Nieman | Chapel Hill, NC | Pediatric Dermatology | $5,615.89 |
| Esteban Fernandez Faith | Columbus, OH | Pediatric Dermatology | $5,376.70 |
| Albert Yan | Philadelphia, PA | Dermatology | $5,328.19 |
| Monique Kumar | Orlando, FL | Pediatric Dermatology | $4,992.55 |
| Mark Siegel | Charleston, SC | Dermatology | $4,888.92 |
| Gina Krakovsky | Washington, DC | Pediatrics (Nurse Practitioner) | $4,785.29 |
| Harper Price | Phoenix, AZ | Pediatric Dermatology | $4,188.63 |
Prescribed Hemangeol?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.